Contemporary Clinical Trials 2009;30(3):269-278. [doi: 10.1016/j.cct.2009.01.004]
Michael S. Robbins, PhD (University of Miami Miller School of Medicine, FL Node), José Szapocznik, PhD (University of Miami Miller School of Medicine, FL Node), Viviana E. Horigian, MD (University of Miami Miller School of Medicine, FL Node), Daniel J. Feaster, PhD (University of Miami Miller School of Medicine, FL Node), Marc J. Puccinelli (University of Miami Miller School of Medicine, FL Node), Petra Jacobs, MD (Center for the Clinical Trials Network, NIDA), Ann Kathleen Burlew, PhD (Crossroads Center/University of Cincinnati, OV Node), Robert C. Werstlein, PhD (Daymark Recovery Services, Inc., FL Node), Ken Bachrach, PhD (Tarzana Treatment Centers, PA Node), Gregory S. Brigham, PhD (Maryhaven, Inc., OV Node).
Brief strategic family therapy (BSFTTM) is a manualized treatment designed to address aspects of family functioning associated with adolescent drug use and behavior problems. Within the National Institute on Drug Abuse's Clinical Trials Network (CTN), BSFTTM is being compared to treatment as usual (TAU) in a multisite, prospective randomized clinical trial for drug using adolescents and their families in outpatient settings (protocol CTN-0014). The effectiveness of BSFTTMis being compared to TAU in reducing adolescent drug use, conduct problems, and sexually risky behaviors as well as in improving family functioning and adolescent prosocial behaviors. This paper describes the following aspects of the study: specific aims, research design and study organization, assessment of primary and secondary outcomes, study treatments, data analysis plan, and data monitoring and safety reporting. (Article (Peer-Reviewed), PDF, English, 2009)
Keywords: Adolescents | Behavior therapy | Brief Strategic Family Therapy (BSFT) | Family therapy | Contemporary Clinical Trials (journal)
Document No: 343, PMID: 19470315, PMCID: PMC3163853.
Submitted by Jack Blaine, MD, CCTN, NIDA, 2/2009.